Risk Management Shapes FDA Policies and Practices

In response to increasing concern about drug safety, FDA has implemented several administrative and policy changes, inclduing the new Office of Pharmacoepidemiology and Statistical Science and a renewed focus on risk assessment.

Related Content:

Quality SystemsRegulatory WatchPharmaceutical Technology-08-02-2002

PTC Therapeutics Gains FDA Approval for AADC Deficiency Gene Therapy

EMA’s CHMP Gives Positive Opinion for Use of Lecanemab in Early Alzheimer’s Disease

J&J’s Balversa Gains MHRA Marketing Authorization as Monotherapy for Bladder Cancer